These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18088198)

  • 1. Depersonalization disorder: pharmacological approaches.
    Sierra M
    Expert Rev Neurother; 2008 Jan; 8(1):19-26. PubMed ID: 18088198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases.
    Sierra M; Baker D; Medford N; Lawrence E; Patel M; Phillips ML; David AS
    Clin Neuropharmacol; 2006; 29(5):253-8. PubMed ID: 16960469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open trial of naltrexone in the treatment of depersonalization disorder.
    Simeon D; Knutelska M
    J Clin Psychopharmacol; 2005 Jun; 25(3):267-70. PubMed ID: 15876908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram-Clonazepam combination for primary depersonalization disorder: a case report.
    Sachdev P
    Aust N Z J Psychiatry; 2002 Jun; 36(3):424-5. PubMed ID: 12060195
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of depersonalization disorder with clomipramine.
    Simeon D; Stein DJ; Hollander E
    Biol Psychiatry; 1998 Aug; 44(4):302-3. PubMed ID: 9715363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate in depersonalization disorder: a case report.
    Foguet Q; Alvárez MJ; Castells E; Arrufat F
    Actas Esp Psiquiatr; 2011; 39(1):75-8. PubMed ID: 21274825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naloxone therapy on depersonalization: a pilot study.
    Nuller YL; Morozova MG; Kushnir ON; Hamper N
    J Psychopharmacol; 2001 Jun; 15(2):93-5. PubMed ID: 11448093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 10. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine in somatopsychic and autopsychic depersonalization.
    Preve M; Mula M; Cassano GB; Pini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1808-9. PubMed ID: 21740948
    [No Abstract]   [Full Text] [Related]  

  • 12. Depersonalization and derealization syndrome: report on a case study and pharmacological management.
    Salgado A; Oliveira L; Sierra-Siegert M; Salgado JV
    Braz J Psychiatry; 2012 Dec; 34(4):505-8. PubMed ID: 23429825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological treatment of kleptomania--review].
    Kozian R; Otto FG
    Psychiatr Prax; 2003 May; 30(4):216-20. PubMed ID: 12768528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine for depersonalization associated with multiple sclerosis.
    Ströhle A; Kümpfel T; Sonntag A
    Am J Psychiatry; 2000 Jan; 157(1):150. PubMed ID: 10618046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of lamotrigine in a resistant case of depersonalization disorder.
    Rosagro-Escámez F; Gutiérrez-Fernández N; Gómez-Merino P; de la Vega I; Carrasco JL
    Actas Esp Psiquiatr; 2011; 39(4):263-6. PubMed ID: 21769750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods.
    Rapp JT; Vollmer TR
    Res Dev Disabil; 2005; 26(6):548-64. PubMed ID: 16303583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report.
    Di Michele V; Bolino F
    Eur Psychiatry; 2004 May; 19(3):185. PubMed ID: 15158931
    [No Abstract]   [Full Text] [Related]  

  • 20. Impulse control disorders: clinical characteristics and pharmacological management.
    Grant JE; Potenza MN
    Ann Clin Psychiatry; 2004; 16(1):27-34. PubMed ID: 15147110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.